CSL LIMITED (CSL) operates in the Pharmaceuticals Biotechnology & Life Sciences industry category. CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally
The most recent ex-dividend date was 10-09-2019. This dividend was $1.454545 and was not franked. and was partially franked at 0%. The date paid for this dividend is 11-10-2019.
The comment on the most recent dividend for CSL states that the Dividend Reinvestment Plan is currently suspended.